Intravenous (IV): 5002000mg per infusion, weekly or biweekly
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
When uncertain, ice is generally safer for new pain, while heat suits ongoing discomfort
Federal, State, and local law enforcement
Its important to note that vitamin B12 is water-soluble, so excess amounts are typically excreted in the urine